← Back
Data updated: Mar 10, 2026
QUEEN HAMAMATSU PET
Pharmaceuticals
QUEEN HAMAMATSU PET is a generic drug manufacturer with 1 FDA-approved products.
2015
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2015-08-31
- Latest
- 2015-08-31
- Applications
- 1